Adaptive Biotechnologies Other Long Term Assets (Quarterly) Analysis

Adaptive Biotechnologies Corp. (ADPT)

17.84 -0.03 (-0.17%) USD | NASDAQ | Jan 21, 09:47

View Other Long Term Assets (Quarterly) for ADPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Zymeworks, Inc.	Upgrade
Cue Biopharma, Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade